Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.
about
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signalingThe rebel angel: mutant p53 as the driving oncogene in breast cancer.TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.RhoJ regulates melanoma chemoresistance by suppressing pathways that sense DNA damageEfficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast CancerTwo different, mutually exclusively distributed, TP53 mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activityFunctional analyses of human DNA repair proteins important for aging and genomic stability using yeast geneticsStudy of Association between Pre-Senile Cataracts and the Polymorphisms rs2228000 in XPC and rs1042522 in p53 in Spanish Population.TP53 mutation, epithelial-mesenchymal transition, and stemlike features in breast cancer subtypesImpact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiationLow-level p53 expression changes transactivation rules and reveals superactivating sequences.The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells.PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis.Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrationsLigand dependent restoration of human TLR3 signaling and death in p53 mutant cells.TP53 mutants in the tower of babel of cancer progression.FGFR2 Amplification in Colorectal Adenocarcinoma.Hsp90 and PKM2 Drive the Expression of Aromatase in Li-Fraumeni Syndrome Breast Adipose Stromal Cells.DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: the same outcome of treatment with different doses in sensitive cell lines.Human transcription factors in yeast: the fruitful examples of P53 and NF-кB.Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk.The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53.Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma.
P2860
Q21133611-AE4D037F-C601-4513-820E-2E671806AD8AQ27686765-1F5CD183-BED0-4FAB-B7A2-5663F5816AFCQ27851687-F9E3F4D3-7434-418C-BD4A-1E26C996E9AAQ28274939-26A3B268-A9E1-42A6-8D9A-5B7201CCA8E5Q33680293-BBBEB209-5ED7-4B16-808C-B0E3AE997786Q33865112-542E44FB-95AD-4A4F-B101-CADA2A5ACAA2Q35002385-8755EC7C-85D6-47E1-A88B-2C73230CCB2DQ35869772-E33B612C-9044-490C-AD80-4E6F5C01FB92Q36036120-A81078FC-186E-45A2-9058-95450452251AQ36148592-2050C0B8-A180-41B6-96A8-01DAB77D2052Q36213310-A5590491-7D87-4F7B-A823-CF4D7104A742Q36221831-BE5B6EA8-F62E-4565-AF8C-E67578A43A71Q36237533-ADD6CAB7-8603-4C23-B482-F2368061B2FEQ36454901-4476480C-85E2-47B9-8575-261169435E46Q36905633-444E2295-9A17-425B-B3B2-7462D17ACBEFQ37641651-423E8DA1-0C94-44C5-AB85-23887554A36BQ38180665-71312913-49AF-4DC3-83BD-B55C973CB09DQ38694309-99377107-07FA-4D2E-8C85-8E53AD326159Q38755170-AF1780EE-AAE4-4F2B-9FB7-AC1D87BCA11FQ38903608-F98A2815-76CD-4FA8-8075-A618A7C983A6Q38967375-A2AAAC58-014E-4EA8-BFDE-97D2BB905394Q46031098-FE6E2B7F-B8AA-4B10-9461-06A9AA58B3D5Q49571721-34AA942D-E5AE-49C2-9C86-D096E8CF3707Q49884832-54517774-4141-4D0E-AB23-4A4DC2FAAF7F
P2860
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Altered-function p53 missense ...... le effects on transactivation.
@ast
Altered-function p53 missense ...... le effects on transactivation.
@en
type
label
Altered-function p53 missense ...... le effects on transactivation.
@ast
Altered-function p53 missense ...... le effects on transactivation.
@en
prefLabel
Altered-function p53 missense ...... le effects on transactivation.
@ast
Altered-function p53 missense ...... le effects on transactivation.
@en
P2093
P2860
P1476
Altered-function p53 missense ...... le effects on transactivation.
@en
P2093
Alberto Inga
Jennifer J Jordan
Kathleen Conway
Lisa A Carey
Michael A Resnick
Sharon Edmiston
P2860
P304
P356
10.1158/1541-7786.MCR-09-0442
P577
2010-04-20T00:00:00Z